Stock HOTH HOTH THERAPEUTICS, INC.
Add to a list
To use this feature you must be a member
Log inSign up

Consensus Hoth Therapeutics, Inc.

Equities

HOTH

US44148G2049

Market Closed - Nasdaq
Other stock markets
 04:00:00 2024-05-31 pm EDT 		5-day change 1st Jan Change
1.17 USD -.--% Intraday chart for Hoth Therapeutics, Inc. -4.10% -18.75%
May. 14 Hoth Therapeutics, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024 CI
Mar. 28 Hoth Therapeutics, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023 CI

Evolution of the average Target Price on Hoth Therapeutics, Inc.

Price target over the last 5 years

History of analyst recommendation changes

def8b2205bef85e26669.0wQH_nweviaFG7lizsXbLH1G2siRxNr0MofklJCkYUw.sWdP0wVmxkzvfNc29_CpT1ANqIf_rYXFA8-vrMTHLDSRMWm_Sn_hEepc9A~c67a82932e09ff16176d2021732498d7

Analyst Recommendations on Hoth Therapeutics, Inc.

HC Wainwright Starts Hoth Therapeutics With Buy Rating, $4 Price Target MT
EF Hutton Cuts Hoth Therapeutics Price Target to $7.50 From $12, Maintains Buy Rating MT
EF Hutton Assumes Hoth Therapeutics at Buy With $14 Price Target MT
Fed Rate Decision Eyed Amid Higher Exchange-Traded Funds, Equity Futures Pre-Bell Wednesday MT
EF Hutton Lowers Price Target on Hoth Therapeutics to $14 From $33, Maintains Buy Rating MT
EF Hutton Lowers Hoth Therapeutics' Price Target to $33 From $45, Keeps Buy Rating MT
More recommendations

Analysts' Consensus

Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
2
Last Close Price
1.17 USD
Average target price
5.5 USD
Spread / Average Target
+370.09%
High Price Target
7 USD
Spread / Highest target
+498.29%
Low Price Target
4 USD
Spread / Lowest Target
+241.88%

Consensus detail

Consensus revision (last 18 months)

Analysts covering Hoth Therapeutics, Inc.

HC Wainwright
EF Hutton

EPS Revisions

Estimates Revisions

Quarterly earnings - Rate of surprise

Company calendar
  1. Stock Market
  2. Equities
  3. HOTH Stock
  4. Consensus Hoth Therapeutics, Inc.